Loading…
Chinese hospital chain specializing in neurosurgery and brain/nervous-system disease treatment.
Chinese hospital chain specializing in neurosurgery and brain/nervous-system disease treatment.
Earns fees from patients, with inpatient surgery and treatment the largest part, paid partly through state medical insurance and partly out of pocket, and grows by opening or acquiring hospitals that take time to fill up and reach profit. Its brain-surgery reputation draws patients from across China.
In one line: A Chinese neurosurgery-focused hospital chain.
Moat: narrow (brand, process know-how). Specialized neurosurgical expertise and reputation versus general hospitals.
Headquarters: Beijing, China · Employees: 2,889
Size Sanbo Hospital Management (301293.SZ) is a China Health Care company (Hospital/Nursing Management) with a market value of $1.48B, the 1657th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥50.63 on 6 Nov 2026.
Performance Over six months the shares fell 21.0%, against -3.0% for the median peer and -16.4% for the China market (cap-weighted) — 2nd lowest of 21 in its peer set.
Growth Revenue grew 17.5% over the last twelve months (peer median +6.5%); the operating margin is 5.8% (peer median 9.9%).
Valuation It trades at 148.9× forward earnings against a peer median of 27.3× (most expensive of 18).
Capital Return on invested capital runs 4.7 points below its cost of capital (10.5% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.93B | CN¥1.72B | CN¥1.43B | CN¥1.31B | CN¥1.07B |
| Revenue growth | — | +21% | +9% | +23% | — |
| Gross profit | CN¥527M | CN¥376M | CN¥325M | CN¥284M | CN¥217M |
| EBITDA | n/a | CN¥271M | CN¥229M | CN¥214M | CN¥181M |
| Net income | CN¥68.3M | CN¥84.2M | CN¥105M | CN¥78.2M | CN¥63.4M |
| Free cash flow | -CN¥38.2M | -CN¥396M | -CN¥371M | CN¥80.9M | CN¥67.2M |
| Capital expenditure | CN¥321M | CN¥586M | CN¥542M | CN¥170M | CN¥90.0M |
| Total debt | CN¥700M | CN¥632M | CN¥277M | CN¥174M | CN¥219M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Sanbo Hospital Management 301293.SZ | $1.48B | -21% | +17% | 6% | 148.9× | n/a |
| Aier Eye Hospital 300015.SZ | $12.5B | -16% | +5% | 21% | 29.5× | 11.7% |
| Huaxia Eye Hospital 301267.SZ | $1.92B | -16% | +2% | 15% | 24.7× | 3.8% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 301293.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +3.2% | -0.3% | 7th highest of 21 |
| 6-month return | -21.0% | -3.0% | 2nd lowest of 21 |
| Distance from 52-week high | -50.8% | -19.7% | lowest of 21 |
| Revenue growth (TTM) | +17.5% | +6.5% | 5th highest of 21 |
| Operating margin | 5.8% | 9.9% | 7th lowest of 20 |
| Forward P/E | 148.9× | 27.3× | most expensive of 18 |
| ROIC minus cost of capital | -4.7 pp | -1.5 pp | 3rd lowest of 20 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Sanbo Hospital Management 301293.SZ | China | $1.48B | -21% | +17% | 6% | 148.9× | n/a | n/a |
| Aevis Victoria AEVS.SW | Switzerland | $1.49B | +9% | +15% | -6% | 107.9× | 26.6% | +10.2% |
| Xi'an International Medical Investment 000516.SZ | China | $1.54B | 0% | -1% | -2% | n/a | 13.6% | +20.6% |
| Sienna Senior Living SIA.TO | Canada | $1.63B | -11% | +16% | 10% | 38.1× | 19.6% | +8.6% |
| Spire Healthcare SPI.L | United Kingdom | $1.34B | +68% | +2% | 8% | 19.5× | 9.8% | +11.4% |
| Rainbow Childrens Medicare RAINBOW.NS | India | $1.34B | -4% | +23% | 22% | 39.4× | 30.2% | +21.2% |
| Raffles Medical BSL.SI | Singapore | $1.25B | -15% | -3% | 11% | 27.3× | -2.4% | +6.1% |
| CVS CVSG.L | United Kingdom | $1.23B | +20% | +6% | 11% | 14.3× | 13.7% | +6.9% |
| Extendicare EXE.TO | Canada | $1.87B | -9% | +31% | 9% | 19.4× | 11.2% | +8.5% |
| Park Medi World PARKHOSPS.NS | India | $1.15B | +2% | +21% | n/a | 28.3× | 30.5% | +10.2% |
| Huaxia Eye Hospital 301267.SZ | China | $1.92B | -16% | +2% | 15% | 24.7× | 3.8% | +10.4% |
| Ramsay Generale de Sante GDS.PA | France | $1.09B | -15% | +3% | 4% | n/a | 6.3% | +6.0% |
| Rhon-klinikum RHK.DE | Germany | $1.08B | +14% | +5% | 3% | 22.5× | n/a | n/a |
| Yatharth Hospital and Trauma Care Services YATHARTH.NS | India | $1.05B | +25% | +50% | 16% | 41.0× | n/a | n/a |
| Brookdale Senior Living BKD | United States | $2.15B | -31% | -4% | 5% | 127.7× | 22.4% | -1.4% |
| Jupiter Life Line Hospitals JLHL.NS | India | $1,000M | +14% | +17% | 16% | 48.5× | n/a | n/a |
| Thomson Medical A50.SI | Singapore | $953M | -21% | +6% | 10% | n/a | 20.9% | +11.8% |
| HealthCare Global Enterprises HCG.NS | India | $950M | -2% | +14% | 8% | 67.3× | n/a | n/a |
| Clinica Baviera CBAV.MC | Spain | $940M | -7% | +11% | 20% | 18.2× | 0.7% | +19.7% |
| Ardent Health ARDT | United States | $2.44B | +71% | +3% | 4% | 14.5× | 4.0% | +8.7% |
| Topchoice Medical 600763.SS | China | $2.51B | -11% | +7% | 26% | 26.7× | 13.6% | +6.9% |